Nestlé to Buy Aimmune Therapeutics in $2.6bn deal

Nestlé to Buy Aimmune Therapeutics in $2.6bn deal

Nestlé Health Science has agreed to acquire Aimmune Therapeutics, a peanut allergy treatment maker, in a deal worth approximately $2.6 billion. Founded in 2011, Aimmune is a biopharmaceutical company which develops and commercialises treatments for patients with food...
Coca-Cola Announces Major Global Restructuring Effort

Coca-Cola Announces Major Global Restructuring Effort

The Coca-Cola Company has announced a major global restructuring effort, which will see the business streamline its operations into nine operating units and establish five ‘global category leads’. The company’s current business model includes 17 business units under...